Eurointervention

Papers
(The TQCC of Eurointervention is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
In search of the origin of the acronym TAVI258
TAVR under 70: is age just a number?141
International variation in modality and outcomes of left main revascularisation: does it really matter?117
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity113
Double-tap to treat paravalvular leak in high-risk annuli105
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study86
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis83
Transcatheter left ventriculoplasty76
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis66
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement59
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s58
Recanalisation of coronary chronic total occlusions53
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry51
Defer-based non-stenting: a promising approach for STEMI48
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure47
Hybrid coronary revascularisation: the best or the worst of both worlds?44
The “road travelled”: reflections on the transformation of information exchange in a digital age43
   Atrial fibrillation and acute coronary syndrome 43
One-month DAPT after acute coronary syndrome: too short or not too short?40
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve37
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study37
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection36
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document36
Redo transcatheter mitral valve replacement in mitral annular calcification35
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation35
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study34
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes34
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis34
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial33
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study32
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial31
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD31
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons30
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement30
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation29
A novel robotic radiation shielding device for interventional cardiology procedures29
Percutaneous versus surgical transaxillary access for transcatheter aortic valve replacement: a propensity-matched analysis of the US experience28
A novel three-dimensional imaging approach to evaluate coronary access before transcatheter aortic valve-in-valve implantation28
Cerebral embolic protection during transcatheter heart interventions28
Retrievable scaffold therapy before paclitaxel drug-coated balloon angioplasty in infrapopliteal arteries: one-year outcomes of the DEEPER OUS Study27
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry27
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry27
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty26
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation26
Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification24
Antithrombotic therapy for transcatheter structural heart intervention24
Oesophageal and gastric injuries caused by transoesophageal probe manipulation in patients undergoing transcatheter edge-to-edge repair for tricuspid regurgitation24
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study24
Shifting focus in bifurcations.23
Optical coherence tomography to visualise the endothelialisation of left atrial appendage occluders23
SYNTAXES, biomarkers and survival in complex coronary artery disease: the intervention of secondary prevention23
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons23
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial22
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients21
Carbon footprint of diagnostic coronary angiography21
Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure21
Procedural and early outcomes of transcatheter edge-to-edge mitral valve repair in very elderly patients21
The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome20
Is transcatheter aortic valve implantation safe in patients with left ventricular outflow tract calcification?20
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons20
Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial20
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome20
FFRangio-guided versus pressure wire-guided PCI: design and rationale of the multicentre, randomised ALL-RISE trial20
The patent foramen ovale does not spontaneously close in patients aged 6019
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions19
UNICA − a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency 19
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias19
New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation19
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation18
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair18
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis18
Targeting inflammation in atherosclerosis: overview, strategy and directions17
SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?16
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?16
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation16
Stent underexpansion in the CRUNCH registry: worth cracking?16
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?15
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry15
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin15
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI15
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis14
Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair14
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry14
EuroIntervention: the 200th issue13
Letter: Caffeine and fractional flow reserve overestimation: a word of caution13
PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease13
Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study12
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interv12
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies12
Device-related thrombus following left atrial appendage occlusion12
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials12
We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons12
0.15653419494629